Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hairy and enhancer of split-related protein HELT (HELT) is a basic helix-loop-helix (bHLH) transcription factor belonging to the HES/HEY-like family, acting as a transcriptional repressor during embryonic neural development[6][11]. HELT preferentially binds to specific DNA sequences, represses neurogenin (Ngn) genes, and determines whether neural progenitors differentiate into GABAergic rather than glutamatergic neurons[9]. HELT shares domain and functional similarities with other HES/HEY transcriptional repressors, exhibiting key roles in cell fate specification and transcriptional regulation during organismal development[6][9]. There are no known drugs, direct therapeutic links, or safety concerns associated with HELT, and it is not used as a clinical biomarker[6][9][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hairy and enhancer of split-related protein HELT (HELT).